PIOGLITAZONE HYDROCHLORIDE
- Product NDC
- 68071-2882
- 11-digit product format
- 680712882
- Labeler code
- 68071
- Product ID
- 68071-2882_edfebcb7-3f16-3c47-e053-2a95a90aa962
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pioglitazone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA200268
- Marketing category
- ANDA
- Marketing start
- 2013-02-13
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2882-1 | 68071288201 | 120 TABLET in 1 BOTTLE (68071-2882-1) | 120 tablet | 2022-11-21 | 0000-00-00 | No | No | Current |